Viewing Study NCT00626860


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2026-01-07 @ 1:30 AM
Study NCT ID: NCT00626860
Status: COMPLETED
Last Update Posted: 2017-03-28
First Post: 2008-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma
Sponsor: Beth Israel Deaconess Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module